Compare Cardinal Health Inc (CAH) vs Vanguard Total World Stock Index Fund ETF (VT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Vanguard Total World Stock Index Fund ETF — how do they compare? Cardinal Health Inc trades at $234.16 (market cap $55.88B), while Vanguard Total World Stock Index Fund ETF trades at $161.54. The key difference: Cardinal Health Inc pays a 0.86% dividend while Vanguard Total World Stock Index Fund ETF pays none. Which is the better fit depends on your goals.
| CAH | VT | |
|---|---|---|
Market Cap | $55.88B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $240.26 | $161.30 |
52-Week Low | $146.04 | $132.19 |
Enterprise Value | $59.91B | — |
Dividend Yield | 0.86% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $235.3, down 0.79% on the day, but remains near its 52-week high. The stock exhibits a bullish technical signal with consistent earnings beats in recent quarters, including Q2 2026 EPS of $2.91 versus $2.42 expected. Revenue for fiscal 2025 was $222.58 billion, with net income reaching $1.56 billion. Analyst consensus is strongly positive, with 18 buys and a $266.43 price target, reflecting confidence in the company's pharmaceutical and specialty business growth.
The outlook for CAH is favorable, driven by robust earnings performance and optimistic fiscal 2027 guidance. Key opportunities include sustained demand for specialty drugs and operational efficiency gains. Risks involve high debt levels, with a debt-to-asset ratio of 16.09 in 2025, and competitive pressures in the healthcare distribution sector. Investors should weigh strong analyst support against balance sheet leverage and market volatility.
Vanguard Total World Stock ETF (VT) trades at $161.53, up 0.35% on the day, with a bullish technical signal from moving averages. The ETF offers diversified global equity exposure across more than 10,000 stocks, with a low expense ratio of 0.06% (Vanguard, 2026). Recent news highlights institutional activity, including Barry Investment Advisors reducing its stake by 18.7% in Q2 2026 (Defense World, 2026-08-10).
VT provides broad market access but faces risks from trade policy uncertainty and potential market volatility. The neutral oscillator signal and overbought RSI levels suggest near-term consolidation. Long-term appeal lies in cost-efficient global diversification, though investors should weigh geopolitical risks against the fund's historical resilience.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Vanguard Total World Stock Index Fund ETF
VT is a foundational, low-cost ETF that seeks to track the FTSE Global All Cap Index, providing exposure to nearly 10,000 stocks across developed and emerging markets worldwide, including the United States. It serves as a single-ticker solution for total global equity diversification, capturing approximately 98% of the world's investable market capitalization.
Read more on VT →
